Showing results (971-980 of 1,396) with videos related to
Sort By:
Pageof 140
JCO Precision Oncology|October 9, 2025
Role of Circulating Tumor DNA Tumor Fraction in Advanced Non-Small Cell Lung Cancer and Its Impact on Patient Treatment Outcomes: A Prospective Real-World StudyBen Man Fei Cheung, Elaine Yee-Ling Ko, David Jen Hao Shih, et al.JCO Precision Oncology|October 16, 2025
Olaparib in Patients With Solid Tumors With BRCA1/2 Alterations: Results From The Targeted Agent and Profiling Utilization Registry (TAPUR) StudyTareq Al Baghdadi, Michael Rothe, Pam K Mangat, et al.JCO Precision Oncology|October 2, 2025
Interactive Use of Cox Model-Predicted Survival Curves: An Application Using ACS10 Score and Age to Personalize Treatment of Pediatric AMLSubodh Selukar, Harrison Clement, Yonghui Ni, et al.JCO Precision Oncology|October 2, 2025
Transgender and Gender-Diverse Patient Perspectives on Hereditary Breast Cancer Risk Assessment in Gender-Affirming Top SurgeriesKimberly Zayhowski, Kai Blumen, Kathleen F Mittendorf, et al.JCO Precision Oncology|August 7, 2025
Comprehensive Comparison of Somatic, Germline, and Immune Cell Profiles in Upper Tract and Bladder Urothelial CarcinomaKit Yuen, Margaret Meagher, Jacob Mercer, et al.JCO Precision Oncology|February 8, 2023
Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine CarcinomaStian Knappskog, Tobias Grob, Andreas Venizelos, et al.JCO Precision Oncology|June 17, 2025
Costs and Benefits of Whole-Exome, Whole-Transcriptome Sequencing in Patients With Advanced Non-Small Cell Lung CancerJesse D Ortendahl, Gebra Cuyun Carter, Snehal G Thakkar, et al.JCO Precision Oncology|June 17, 2025
BRCA1-Associated Protein 1 and Enhancer of Zeste Homolog 2: Pathway Interaction and Therapeutic Intervention in Breast Cancer, Mesothelioma, and LymphomaElizabeth Casey West, Jessica Evangelista, Annalisa Campanella, et al.JCO Precision Oncology|June 11, 2025
Utility of Tumor-Informed Circulating Tumor DNA for Monitoring Treatment Response in Nonmetastatic, Locally Advanced Penile and Primary Urethral CancersKartik R Patel, Sol C Moon, Luke A Shumaker, et al.JCO Precision Oncology|April 3, 2025
Constitutional Epimutations: From Rare Events Toward Major Cancer Risk Factors?Per Eystein Lønning, Oleksii Nikolaienko, Stian KnappskogPageof 140